New Atlas2d
First new stroke and UTI drugs in 30 years get FDA approval
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
Jacobs School of Medicine and Biomedical Sciences - University at Buffalo4d
Study Compares Hypervirulent Infections
Thomas A. Russo, MD, SUNY Distinguished Professor and chief of infectious diseases at the Jacobs School, is co-author on a Nature Communications paper analyzing hypervirulent pneumoniae infections.
ConsumerAffairs7d
New drug to treat UTIs gets federal approval
The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...
FDA approves new UTI antibiotic that may help patients with recurring infections
Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...
BioPharma Dive6d
FDA approves first-of-its-kind antibiotic from GSK
The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...
Fierce Pharma7d
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
Bacteria in recalled shampoo linked to eye, nose and skin infections
Mexican company Henkel Capital S.A. de C.V. recalled its contaminated Tec Italy shampoo that was distributed in New York and ...
Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More
SAVA and ALNY are in the spotlight this week following a study failure and label expansion of lead drug, respectively.
Becker's Hospital Review7d
FDA approves antibiotic to treat UTIs for 1st time in 30 years
The FDA has approved GSK’s gepotidacin, the first antibiotic for uncomplicated urinary tract infections in 30 years. The drug has been approved for female adults and adolescents with UTIs caused by ...
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
TUESDAY, March 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women ...